Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11182-11198
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11182
Table 3 Pancreatic ductal adenocarcinomas screening efforts and diagnostic yields n (%)
Ref.Number screenedHigh-risk groupInitial imaging (if abnormal screening)Diagnostic yieldDefinition of diagnostic yield
Brentnall et al[182]14FPCEUS + ERCP + CT7 (50)Dysplasia
Rulyak et al[183]35FPCIf symptomatic: EUS + ERCP If asymptomatic: EUS (ERCP)12 (34.3)Dysplasia
Kimmey et al[184]46FPCEUS (ERCP)12 (26)Dysplasia
Canto et al[185]38FPC, PJSEUS (CT, ERCP, EUS-FNA)2 (5.3)PDAC, IPMN
Canto et al[186]78FPC, PJSEUS + CT (ERCP, EUS-FNA)8 (10.3)IPMN, PanIN1-2
Poley et al[187]44FPC, BRCA, PJS, FAMMM, p53, HPEUS (CT, MRI)10 (23)PDAC, IPMN on imaging
Langer et al[188]76FPC, BRCA, FAMMMEUS + MRCP (EUS)1 (1.3)IPMN
Verna et al[181]51FPC, PJS, FAMMM, BRCA, HP, HNPCCEUS and/or MRCP (EUS-FNA, ERCP)6 (12)1PDAC, IPMN, multifocal PanIN2-3
Ludwig et al[189]109FPC, BRCAMRCP (EUS)9 (8.3)PDAC, IPMN, PanIN2-3, SCA on imaging
Vasen et al[190]79p16MRI/MRCP, EUS if unable7 (8.9)PDAC
Al-Sukhni et al[191]262FPC, FDR of double-primary cancer, BRCA, PJS, HP, p16MRI (ERCP, EUS, CT)3 (1.1)2PDAC
Schneider et al[33]72FPC, BRCA, PALB2, p16EUS + MRCP (EUS)4 (5.5)MD-IMPN, multifocal PanIN23
9 (12.5)MD-IMPN, multifocal PanIN2-3, BD-IPMN
Canto et al[174]216FPC, BRCA, PJSCT + MRI/MRCP + EUS (ERCP)92 (42.6)Pancreatic lesion